| Issue | Title | |
| Vol 11, No 2 (2018) | Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia | Abstract PDF (Rus) |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Abstract PDF (Rus) |
| N. A. Avxentyev, M. Yu. Frolov | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic aspects of COVID-19 treatment | Abstract PDF (Rus) |
| I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich | ||
| Vol 10, No 2 (2017) | PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY | Abstract PDF (Rus) |
| A. V. Rudakova, S. A. Protsenko, I. A. Koroleva | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price | Abstract PDF (Rus) |
| D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract PDF (Rus) |
| A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
| Vol 11, No 1 (2018) | Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia | Abstract PDF (Rus) |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| Vol 13, No 1 (2020) | Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy | Abstract PDF (Rus) |
| S. K. Zyryanov, I. N. Diyakov | ||
| Vol 17, No 1 (2024) | Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer | Abstract PDF (Rus) |
| S. К. Zyryanov, I. N. Dyakov | ||
| Vol 8, No 4 (2015) | PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER | Abstract PDF (Rus) |
| D. A. Zhukov | ||
| Vol 10, No 2 (2017) | PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA | Abstract PDF (Rus) |
| M. Yu. Frolov, O. V. Shatalova | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT | Abstract PDF (Rus) |
| N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer | Abstract PDF (Rus) |
| Yu. Yu. Petukhova, E. V. Eliseeva, M. V. Volkov, O. N. Li, A. G. Petukhova | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER | Abstract |
| A. U. Kulikov | ||
| Vol 5, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION | Abstract |
| V. G. Serpik, R. I. Yagudina | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET | Abstract |
| R. I. Yagudina, V. G. Serpik | ||
| Vol 13, No 4 (2020) | Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy | Abstract PDF (Rus) |
| I. N. Dyakov, S. R. Varfolomeеva | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital | Abstract PDF (Rus) |
| L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva | ||
| Vol 10, No 4 (2017) | PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION | Abstract PDF (Rus) |
| M. Yu. Frolov, V. A. Rogov | ||
| Vol 6, No 2 (2013) | PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION | Abstract |
| V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina | ||
| Vol 8, No 2 (2015) | PHARMACOECONOMIC STUDIES TREATMENT OF PATIENTS WITH INJURIES IN THE DEPARTMENT OF ANESTHESIOLOGY AND RESUSCITATION WITH METHODS ANALYSIS THE COST OF ILLNESS | Abstract PDF (Rus) |
| Anton Alexandrovich Kasatkin | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract PDF (Rus) |
| A. V. Rudakova, Т. V. Korotaeva | ||
| Vol 16, No 4 (2023) | Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer | Abstract PDF (Rus) |
| E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION | Abstract PDF (Rus) |
| M. Yu. Frolov, V. A. Rogov | ||
| Vol 6, No 4 (2013) | Pharmacoeconomic study of nutrition support in the conditions of current health care system in Russia | Abstract |
| I. A. Metelkin, R. I. Yagudina | ||
| Vol 9, No 4 (2016) | PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION | Abstract PDF (Rus) |
| D. S. Kaskaeva, M. M. Petrova, O. V. Zimnitskaya | ||
| Vol 9, No 4 (2016) | PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION | Abstract PDF (Rus) |
| D. S. Kaskaeva, M. M. Petrova, O. V. Zimnitskaya | ||
| Vol 18, No 2 (2025) | Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis | Abstract PDF (Rus) |
| J. A. Agafonova | ||
| Vol 6, No 2 (2013) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS | Abstract |
| A. Yu. Kulikov, V. G. Serpik | ||
| Vol 5, No 2 (2012) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS | Abstract |
| A. Yu. Kulikov, V. G. Serpikov | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS | Abstract PDF (Rus) |
| M. V. Protsenko | ||
| Vol 6, No 1 (2013) | PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION | Abstract |
| R. I. Yagudina, I. Yu. Zinchuk | ||
| Vol 15, No 2 (2022) | Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis | Abstract PDF (Rus) |
| O. S. Mikhaylova, A. V. Krikova | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities | Abstract PDF (Rus) |
| R. E. Kalinin, I. A. Suchkov, M. M. Uporov, D. S. Titov, M. Yu. Klishchenko | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract |
| A. U. Kulikov, I. A. Komarov | ||
| Vol 9, No 1 (2016) | PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS | Abstract PDF (Rus) |
| O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina | ||
| Vol 6, No 4 (2013) | Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital | Abstract PDF (Rus) |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| Vol 6, No 4 (2013) | Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation | Abstract |
| A. Yu. Kulikov, L. A. Komarov | ||
| Vol 5, No 1 (2012) | PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING | Abstract PDF (Rus) |
| M. V. Protsenko, N. I. Koroleva | ||
| Vol 12, No 3 (2019) | Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings | Abstract PDF (Rus) |
| O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev | ||
| Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract PDF (Rus) |
| O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
| Vol 16, No 2 (2023) | Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure | Abstract PDF (Rus) |
| O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov | ||
| Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract PDF (Rus) |
| D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
| Vol 14, No 2 (2021) | Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis | Abstract PDF (Rus) |
| N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova | ||
| Vol 18, No 3 (2025) | Pharmacoepidemiology of anxiolytics in the Russian Federation | Abstract PDF (Rus) |
| Yu. M. Gomon, A. S. Kolbin, V. A. Lavrova, N. G. Neznanov, D. N. Nuriakhmitova | ||
| Vol 7, No 3 (2014) | PHARMACOEPIDEMIOLOGY OF ORIGINAL DROTAVERINE USE IN DYSMENORRHEA: RESULTS OF AN INTERNATIONAL MULTICENTER STUDY | Abstract PDF (Rus) |
| A. L. Unanyan, V. A. Alimov, S. E. Arakelov, M. S. Afanasyev, D. V. Baburin, D. V. Blinov, T. D. Guriyev, U. V. Zimovina, A. E. Kadyrova, Yu. M. Kossovich, L. S. Polonskaya | ||
| Vol 5, No 2 (2012) | PHARMACOEPIDEMIOLOGY OF PHYSICIANS’ INDICATIONS IN PATIENTS WITH POSTINFARCTIONCARDIOSCLEROSIS | Abstract PDF (Rus) |
| O. N. Kurochkinа, A. L. Khokhlov, N. M. Boyankova | ||
| Vol 6, No 4 (2013) | Pharmacoepidemiology of stroke treatment in different hospitals | Abstract PDF (Rus) |
| N. V. Mikheeva, O. V. Reshetko, L. G. Ryzhenkova | ||
| Vol 7, No 1 (2014) | PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE | Abstract PDF (Rus) |
| S. A. Rachina, R. S. Kozlov, Yu. A. Belkova | ||
| Vol 15, No 2 (2022) | Pharmacotherapy of insomnia in childhood | Abstract PDF (Rus) |
| Z. G. Tadtaeva, A. N. Galustyan, V. V. Rusanovsky, O. A. Gromova, I. S. Sardaryan, M. Yu. Krivdina, N. A. Kuritsyna | ||
| 351 - 400 of 539 Items | << < 3 4 5 6 7 8 9 10 11 > >> | |
Browse Title Index
Popular articles
Vol 10, No 1 (2017)
Vol 17, No 3 (2024)
Vol 16, No 3 (2023)
Vol 16, No 4 (2023)
Vol 13, No 1 (2020)
Vol 14, No 4 (2021)
Keywords
COVID-19
artificial intelligence
budget impact analysis
chemotherapy
children
chondroitin sulfate
clinical and economic analysis
cost minimization analysis
cost-effectiveness analysis
cost-utility analysis
drug supply
drugs
glucosamine sulfate
health technology assessment
oncology
pharmaceutical market
pharmacoeconomic analysis
pharmacoeconomics
pharmacoepidemiology
pharmacoinformatics
quality of life
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
